Official approval has been sought to make Forxiga (dapagliflozin) the first sodium-glucose co-transporter-2 (SGLT2) inhibitor available to treat people with chronic heart failure in Europe. The ...
A high percentage of people with diabetes are deliberately letting their blood sugar reach high levels in a bid to avoid hypos, a new survey has found. The poll, carried out as part of Hypo ...
Almost 300,000 people have accessed the online type 2 diabetes risk score tool to in the last two months, according to the NHS. Latest figures show that 291,325 people used the Diabetes UK Know ...
Draft guidelines for the diagnosis and management of type 1 and type 2 diabetes among children and young people are currently out for consultation. NICE has asked registered stakeholders to ...
Cardiovascular disease must be “prioritised” and made a “key factor” in the management of type 2 diabetes, according to researchers from a major study. The findings ...
Type 1 and type 2 diabetes were both independently associated with a significant increased odds of in-hospital death with COVID-19, according to new research. The study findings led by Jonathan ...
Less than half of women with gestational diabetes undergo a guideline-recommended test for type 2 diabetes within 12 weeks of delivery, according to a poster unveiled at the virtual 56th EASD ...
Achieving type 2 diabetes remission through a low-calorie, weight management programme can restore the pancreas to a normal size, new research has found. The findings were unveiled at the ...
Bitesize information to help GPs “navigate the complexities” of treating people with type 2 diabetes and other health conditions has been released. The guidance has been put together ...
A trio of top experts will give primary care services a “helping hand” to better understand a specific type 2 diabetes medication. Leicester researchers have published a new training programme ...